TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data

Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and high mortality rates. It remains a prevailing clinical need to distinguish whether the patient can benefit from therapy, such as chemotherapy. By integrating single-cell and global transcriptome data, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Peifeng, Luo, Yang, Wu, Ningzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543705/
https://www.ncbi.nlm.nih.gov/pubmed/37791059
http://dx.doi.org/10.1515/biol-2022-0707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543705/
https://www.ncbi.nlm.nih.gov/pubmed/37791059
http://dx.doi.org/10.1515/biol-2022-0707

Ejemplares similares